OLMA 13D/13G Filings - Olema Pharmaceuticals Inc.

Real time Form 13D and 13G transaction reports:

Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
Shares have beem adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Goto Prev, 0, 1, 2

Reported DateTime	Transaction Date	Type	Company Symbol	Filed By Symbol	Shares Owned % Owned	Shares Vs. Prev Report	View
2021-12-02 5:05 pm Purchase	2021-11-30	13D	Olema Pharmaceuticals, Inc. OLMA	BIOTECHNOLOGY VALUE FUND L P	7,411,503 18.400%	750,000 (+11.26%)	Filing History
2021-02-16 4:39 pm Purchase	2020-12-31	13G	Olema Pharmaceuticals, Inc. OLMA	RA CAPITAL MANAGEMENT L.P.	2,150,404 5.400%	2,150,404 (New Position)	Filing History
2021-02-16 3:24 pm Sale	2020-12-31	13G	Olema Pharmaceuticals, Inc. OLMA	Cormorant Asset Management LP	3,195,544 7.960%	-75,000 (-2.29%)	Filing History
2021-02-12 3:42 pm Purchase	2020-12-31	13G	Olema Pharmaceuticals, Inc. OLMA	JANUS HENDERSON GROUP PLC JHG	3,638,838 9.100%	3,638,838 (New Position)	Filing History
2021-02-04 09:51 am Purchase	2020-12-31	13G	Olema Pharmaceuticals, Inc. OLMA	Wellington Management Group LLP	2,069,315 5.150%	2,069,315 (New Position)	Filing History
2020-12-03 4:06 pm Purchase	2020-11-23	13D	Olema Pharmaceuticals, Inc. OLMA	Logos Global Management LP	3,758,818 9.400%	3,758,818 (New Position)	Filing History
2020-11-23 4:59 pm Purchase	2020-11-23	13G	Olema Pharmaceuticals, Inc. OLMA	Cormorant Asset Management LP	3,270,544 8.140%	3,270,544 (New Position)	Filing History
2020-11-20 5:23 pm Purchase	2020-11-19	13D	Olema Pharmaceuticals, Inc. OLMA	BIOTECHNOLOGY VALUE FUND L P	6,661,503 16.600%	6,661,503 (New Position)	Filing History

Goto Prev, 0, 1, 2